Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3310
Selected: 0
NCT IDTitle
NCT00866749Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma
NCT05497778A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancreatic Cancer.
NCT03050762Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease
NCT00511641Quality of Life Associated With a Low-Risk Screening Program for Ovarian Cancer
NCT05394337Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial Carcinoma
NCT05349227Comprehensive Outcomes for After Cancer Health
NCT02508662Registry Study for Personalized Cancer Therapy
NCT056743963-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized Trial
NCT01262027TKI258 for Metastatic Inflammatory Breast Cancer Patients
NCT05054413Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method
NCT06043323A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
NCT03485950Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam
NCT06065462Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100
NCT04890834Dyadic Yoga Intervention for the Improvement of Healthcare Utilization and Quality of Life in Patients With Head and Neck Cancer Undergoing Chemoradiation and Their Caregivers
NCT02095834Carfilzomib, Bendamustine Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
NCT01008787Motivational Interviewing for Physical Activity
NCT03219047Patient-Derived Xenografts in Personalizing Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma
NCT06284460Phase I/II Study of a Combination of Decitabine and Cedazuridine (ASTX727) and ASTX029, an ERK Inhibitor, for Patients With RAS Pathway Mutant Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms
NCT03763162Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
NCT00476294Long-Term Follow Up Study for AMD3100 Patients
NCT00500422Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients
NCT05609331Feasibility, Safety, and Efficacy of Stereotactic MRI-Guided Adaptive Radiation Therapy (SMART) for Central Lung Tumors
NCT01120353Childhood Cancer Survivor Study
NCT01815346Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG
NCT02989129Trial of Quercetin in the Treatment and Prevention of Chemotherapy-induced Neuropathic Pain in Cancer Patients
NCT00879437Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma
NCT05012371Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer
NCT00806598Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome
NCT03575949Standard and Delayed FDG PET/CT After Chemoradiation Therapy in Assessing Patients With Metastatic Head and Neck Squamous Cell Cancer
NCT00496587Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma
NCT06420206Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center
NCT04785287Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies
NCT05038098Magnetic Sentinel Lymph Node Mapping in Gastric Cancer
NCT07377006Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer
NCT00378781Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection
NCT04022239Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant
NCT02089230MEK Inhibitor 162 Relapsed and/or Refractory Acute Myeloid Leukemia (AML) and Poor Prognosis, Not Suitable for or Unwilling to Receive Standard Therapy
NCT01193530The Use of Light Therapy for Managing Sleep Disturbances in Patients With Advanced Cancer
NCT04516122Bone Loss in Melanoma Survivors Receiving Immunotherapy
NCT02389751Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal Cancer
NCT00867477PMRR-NO: Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide
NCT04553757Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma
NCT00968253RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia
NCT04759911Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer
NCT04871139An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer
NCT00038675Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate
NCT05030675Fostamatinib for the Treatment of Lower-risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia Who Have Failed Therapy With Hypomethylating Agents
NCT07140757Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers
NCT05046067Feasibility Study of Anatomical Modeling for Image Guided Thoracic Surgery
NCT00506857Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support